Malaise and Rhabdomyolysis

Summary:

Rhabdomyolysis is found among people with Malaise, especially for people who are male, 30-39 old.

The study analyzes which people have Rhabdomyolysis with Malaise. It is created by eHealthMe based on reports of 19 people who have Malaise from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Malaise?

Malaise (a feeling of general discomfort or uneasiness) is found to be associated with 3,488 drugs and 5,129 conditions by eHealthMe. Check the latest studies of Malaise.

What is Rhabdomyolysis?

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down) is found to be associated with 1,556 drugs and 1,922 conditions by eHealthMe. Check the latest studies of Rhabdomyolysis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

19 people who have Malaise and Rhabdomyolysis are studied.

Would you have Rhabdomyolysis when you have Malaise?

Gender of people who have Malaise and experienced Rhabdomyolysis *:

female: 0.0 %
male: 100 %

Age of people who have Malaise and experienced Rhabdomyolysis *:

Common co-existing conditions for these people *:

Fever: 11 people, 57.89%
Muscle Aches (muscle pain): 10 people, 52.63%
Cough: 10 people, 52.63%
Headache (pain in head): 9 people, 47.37%
Diarrhea: 7 people, 36.84%
Cardiac Failure Congestive: 7 people, 36.84%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 36.84%
High Blood Cholesterol: 7 people, 36.84%
Diabetes: 7 people, 36.84%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 5 people, 26.32%

Common drugs taken by these people *:

Kaletra: 8 people, 42.11%
Furosemide: 7 people, 36.84%
Levothyroxine Sodium: 7 people, 36.84%
Acetaminophen And Codeine Phosphate: 7 people, 36.84%
Aspirin: 7 people, 36.84%
Cyclosporine: 7 people, 36.84%
Simvastatin: 6 people, 31.58%
Everolimus: 5 people, 26.32%
Acetaminophen: 5 people, 26.32%
Prednisolone: 5 people, 26.32%

Common symptoms for these people *:

Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 10 people, 52.63%
Headache (pain in head): 10 people, 52.63%
Interstitial Nephritis (inflammation of the kidney): 10 people, 52.63%
Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 10 people, 52.63%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 10 people, 52.63%
Transaminases Increased: 10 people, 52.63%
Muscle Aches (muscle pain): 10 people, 52.63%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 10 people, 52.63%
Nausea (feeling of having an urge to vomit): 10 people, 52.63%
Nausea And Vomiting: 10 people, 52.63%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rhabdomyolysis?

- Check whether Rhabdomyolysis is associated with a drug or a condition

Related publications that referenced our studies

Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .
Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .

Related studies:

Treatments, associated drugs and conditions:

Malaise (529,933 reports)
Rhabdomyolysis (60,893 reports)

All the drugs that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,556 drugs)

All the conditions that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,922 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rhabdomyolysis and Malaise, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.